In the article, Ong and co-authors try to get a fuller picture of antibody responses in SARS-CoV-2 infections:
“Many questions remain regarding the biology and immunology related to SARS-CoV-2. Our extensive profiling of epitope-level resolution antibody reactivity in COVID-19 convalescent patients, confirmed by independent assays, provides new epitopes that could serve as important targets in the development of improved diagnostics, vaccines, and therapeutics against SARS-CoV-2 and dangerous human CoVs that may emerge in the future.”
Read the whole article here. Incredible work, Dr. Ong!